Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Structural Biology of the S1P1 Receptor.
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Exome sequencing to find rare variants causing neurologic diseases.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Current options for the treatment of optic neuritis.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Notch Signaling Regulates T Cell Accumulation and Function in the Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis and herpesvirus interaction.
Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
[Neuromyelitis optica in children. Two case reports.]
Postural orthostatic tachycardia syndrome associated with multiple sclerosis.
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »